Skip to content

Korean Chronic Obstructive Pulmonary Disease(COPD) Assessment Test Validation Study

Validation of the New COPD Assessment Test Translated Into Korean in Patients With Chronic Obstructive Pulmonary Disease

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01424527
Acronym
CAT
Enrollment
100
Registered
2011-08-29
Start date
2010-12-31
Completion date
2011-04-30
Last updated
2017-05-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Keywords

Chronic Obstructive Pulmonary Disease(COPD), COPD Assessment Test(CAT)

Brief summary

This is a cross-sectional validation study, designed to evaluate the discriminative validity of the Chronic Obstructive Pulmonary Disease Assessment Test translated in a local language in patients with Chronic Obstructive Pulmonary Disease.

Detailed description

The Chronic obstructive pulmonary disease Assessment Test is a new questionnaire that has been developed recently to improve communication between doctors and patients. It is known to have good relationship with other measures of quality of life. For the wider application to practice, it has been translated into a local language in many countries.

Interventions

None listed

Sponsors

GlaxoSmithKline
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Subjects eligible for enrolment in the study must meet all of the following criteria: 1. Type of subject: Outpatients 2. Informed consent: Subjects must give their signed and dated written informed consent to participate. 3. Gender: Male or Female 4. Age: 40 years of age or older at a clinic visit 5. COPD diagnosis: Subjects with an established diagnosis of COPD in the past 6 months or before. 6. Tobacco use: Smokers or ex-smokers with a smoking history of more than 10 pack years.

Exclusion criteria

1. Asthma: Subjects with a current diagnosis of asthma. Subjects with a prior history of asthma are eligible if COPD is the current diagnosis. 2. Lung diseases: Subjects with current active respiratory disorders other than COPD, e.g. lung cancer, tuberculosis. 3. Non-compliance: Unable to complete questionnaires

Design outcomes

Primary

MeasureTime frameDescription
Correlation coefficient of the Chronic obstructive pulmonary disease Assessment Test with St George's Respiratory Questionnaire1 dayCorrelation coefficient of the Chronic obstructive pulmonary disease Assessment Test with St George's Respiratory Questionnaire

Secondary

MeasureTime frameDescription
Correlation coefficient of the Chronic obstructive pulmonary disease Assessment Test with Medical Research Council Dyspnea Index1 dayCorrelation coefficient of the Chronic obstructive pulmonary disease Assessment Test with Medical Research Council Dyspnea Index
Correlation coefficient of the Chronic obstructive pulmonary disease Assessment Test with Forced expiratory volume in 1 second value.1 dayCorrelation coefficient of the Chronic obstructive pulmonary disease Assessment Test with Forced expiratory volume in 1 second

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026